Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins (Q40797044)

23 September 2017

title

Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins (English)

1 reference

23 September 2017

main subject

multiple drug resistance

1 reference

van Steenbrugge GJ

1 reference

23 September 2017

Schröder FH

1 reference

23 September 2017

van Brussel JP

1 reference

23 September 2017

Romijn JC

series ordinal

1 reference

23 September 2017

Mickisch GH

series ordinal

1 reference

23 September 2017

publication date

1 April 1999

1 reference

European Journal of Cancer

23 September 2017

published in

1 reference

23 September 2017

1 reference

23 September 2017

1 reference

23 September 2017

page(s)

664-671

1 reference

The epidemiology of prostatic cancer. Geographical distribution and time-trends

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Hormonal Therapy of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Management of relapsing disease in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Glutathione S-transferases: gene structure, regulation, and biological function

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Establishment of a new prostatic carcinoma cell line (TSU-Pr1).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Isolation of a human prostate carcinoma cell line (DU 145)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP-r.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Decreased levels of topoisomerase II alpha in human renal cell carcinoma lines resistant to etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Establishment and in vivo characterization of multidrug-resistant dunning R3327 rat prostate-carcinoma cell-lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Pseudomonas exotoxin conjugated to monoclonal antibody MRK16 specifically kills multidrug resistant cells in cultured renal carcinomas and in MDR-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Expression of a multidrug resistance gene in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900435-3

7 January 2021

10.1016/S0959-8049(98)00435-3

Identifiers

DOI

1 reference

23 September 2017

1 reference